Evidence map›Paper›PMID 28820484›Full record

ReviewInternational journal of molecular sciences2017

Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.

Katalin Koltai, Gabor Kesmarky, Gergely Feher, Antal Tibold, Kalman Toth

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 126 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Whole Blood Aggregometry in Mice.Current protocols · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. In vitro Hemostatic Functions of Cold-Stored Platelets.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2024
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Katalin KoltaiFirst Department of Medicine, University of Pecs, Pecs 7624, Hungary. koltai.katalin@pte.hu.
Gabor KesmarkyFirst Department of Medicine, University of Pecs, Pecs 7624, Hungary. kesmarky.gabor@pte.hu.
Gergely FeherHospital of Szigetvar, Szigetvar 7900, Hungary. feher.gergely@pte.hu.
Antal TiboldDepartment of Public Health Medicine, University of Pecs, Pecs 7624, Hungary. tibold.antal@pte.hu.
Kalman TothFirst Department of Medicine, University of Pecs, Pecs 7624, Hungary. toth.kalman@pte.hu.
University of Pecs · HUResearch Institute for Fisheries and Aquaculture · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelets play a fundamental role in normal hemostasis, while their inherited or acquired dysfunctions are involved in a variety of bleeding disorders or thrombotic events. Several laboratory methodologies or point-of-care testing methods are currently available for clinical and experimental settings. These methods describe different aspects of platelet function based on platelet aggregation, platelet adhesion, the viscoelastic properties during clot formation, the evaluation of thromboxane metabolism or certain flow cytometry techniques. Platelet aggregometry is applied in different clinical settings as monitoring response to antiplatelet therapies, the assessment of perioperative bleeding risk, the diagnosis of inherited bleeding disorders or in transfusion medicine. The rationale for platelet function-driven antiplatelet therapy was based on the result of several studies on patients undergoing percutaneous coronary intervention (PCI), where an association between high platelet reactivity despite P2Y12 inhibition and ischemic events as stent thrombosis or cardiovascular death was found. However, recent large scale randomized, controlled trials have consistently failed to demonstrate a benefit of personalised antiplatelet therapy based on platelet function testing.

Indexed as

Blood PlateletsHumansPlatelet AdhesivenessPlatelet AggregationPlatelet Aggregation InhibitorsPlatelet Function TestsReproducibility of ResultsSensitivity and SpecificityThrombosisTiclopidinePlatelet Aggregation InhibitorsTiclopidineaggregometryaspirinclopidogrelplatelet aggregationplatelet function disorderstailored antiplatelet therapythienopyridines

Identifiers

PMID28820484
PMCPMC5578190
OpenAlexW2749380908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.